MECP2 mutation database launched to study Rett syndrome:
This article was originally published in Clinica
Executive Summary
Researchers at Edinburgh University yesterday (October 2 2003) launched an interactive database to study Rett syndrome. This neurological disorder affects mainly girls, occurring once in every 10-15,000 female births, making it the second most common cause of mental retardation after Down's syndrome. It is commonly associated with a mutation in the MECP2 gene. The project (www.MeCP2.org.uk) led by Dr Brian Hendrich and Dr Skirmantas Kriaucionis aims to help understand how certain symptoms correlate with different mutations and how symptoms change over time.
You may also be interested in...
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.